Improving Capacity Of Aboriginal And Torres Strait Islander Communities To Influence Food Systems For Food Security
Funder
National Health and Medical Research Council
Funding Amount
$1,620,683.00
Summary
The proposed project represents a structured collaborative, continuous improvement and capacity-building approach to improving food security in remote Indigenous communities. It aims to trial a monitoring and evaluation learning approach to assist community based organisations and services to improve the food system and services they deliver to provide an affordable and healthy food supply.
HTLV-1 is a lifelong infection of immune cells that sustains high infection rates up to 45% in key Australian communities. Despite HTLV-1 causing serious malignancy and inflammatory co-morbidities that shorten lifespan, few biomedical interventions are available. We will examine how the virus grows and alters immune responses to cause disease. With this, we can develop antiviral treatments to reduce virus infected cells, and make new diagnostic biomarker assays suitable for remote settings.
A Comprehensive Self-Management Programme For Chronic Obstructive Pulmonary Disease In The Community
Funder
National Health and Medical Research Council
Funding Amount
$391,610.00
Summary
Chronic obstructive pulmonary disease (COPD) is the third leading cause of burden of disease in Australia. It has a major impact on sufferers, their carers and society. This study introduces a new model of community care, based on case management, mentoring to improve self-efficacy and information systems to deliver information and closely monitor disease status. This will improve the quality of life of sufferers, develop healthcare networks and decrease healthcare utilisation.
CCRE In Circulatory And Associated Conditions In Urban Indigenous Peoples
Funder
National Health and Medical Research Council
Funding Amount
$2,157,075.00
Summary
This Centre will focus on improving the prevention and management of circulatory and associated diseases in Aboriginal and Torres Strait Islander peoples living in urban areas. The Centre will conduct and promote high quality research that will lead to improved workforce development and training and service delivery to Urban Indigenous populations. The research program will be conducted jointly with the Queensland Aboriginal Islander Health Forum.
Characterisation Of The Key Role Played By The Persistent Phase Of Chlamydia Pneumoniae In Disease Pathogenesis
Funder
National Health and Medical Research Council
Funding Amount
$286,320.00
Summary
Chlamydia pneumoniae is a relatively newly identified pathogen that is responsible for several respiratory conditions such as, pneumonia and chronic obstructive pulmonary disease and has been strongly linked to heart disesae. Serious disease is due to low grade chronic infections, but we do not understand how the bacterium causes these chronic diseases. This project will identify markers of chronic C. pneumoniae infections and relate these to the disease that results. Identifying these markers o ....Chlamydia pneumoniae is a relatively newly identified pathogen that is responsible for several respiratory conditions such as, pneumonia and chronic obstructive pulmonary disease and has been strongly linked to heart disesae. Serious disease is due to low grade chronic infections, but we do not understand how the bacterium causes these chronic diseases. This project will identify markers of chronic C. pneumoniae infections and relate these to the disease that results. Identifying these markers of chronic disease should lead to improved methods of disease control, including new diagnostic tests, vaccines and new drug therapies.Read moreRead less
Optimising The Therapeutic Efficacy Of Anti-inflammatory Macrophages For Use In Chronic Kidney Diseases
Funder
National Health and Medical Research Council
Funding Amount
$605,096.00
Summary
Chronic kidney disease (CKD) is a major cause of death and morbidity in Australia. Current treatments that are able to delay progression for CKD are limited. As a consequence, more than 2300 additional Australians need kidney replacement each year and many more die of kidney failure. We have reduced and prevented injury in a mouse model of CKD by administering protective white blood cells - macrophages. This project will modify macrophages ex vivo to optimize them for use as a therapy for CKD.